The Fight Against COVID19
23.09k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The Fight Against COVID19 | -1.05% | - | - | - |
| ^GSPC | +0.08% | +2.08% | +22.74% | +4913.82% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 167.84 | -0.92 | -0.55% | 4:00 pm GMT-5 | 5.85M | 7.47M | 441.86B |
| PFE | Pfizer Inc. | 54.95 | -0.59 | -1.06% | 4:02 pm GMT-5 | 27.07M | 43.04M | 308.43B |
| ABBV | AbbVie Inc. | 135.87 | +2.35 | +1.76% | 4:02 pm GMT-5 | 10.48M | 6.36M | 240.20B |
| SNY | Sanofi | 51.93 | +1.20 | +2.37% | 4:00 pm GMT-5 | 1.98M | 1.59M | 130.37B |
| GSK | GlaxoSmithKline plc | 45.47 | +0.41 | +0.91% | 4:00 pm GMT-5 | 3.40M | 4.04M | 114.40B |
| GILD | Gilead Sciences, Inc. | 71.77 | -0.11 | -0.15% | 4:00 pm GMT-5 | 8.34M | 7.14M | 90.03B |
| MRNA | Moderna, Inc. | 204.73 | -5.44 | -2.59% | 4:00 pm GMT-5 | 10.17M | 11.60M | 83.01B |
| REGN | Regeneron Pharmaceuticals, Inc. | 615.24 | -0.87 | -0.14% | 4:00 pm GMT-5 | 791.99k | 746.74k | 66.16B |
| BNTX | BioNTech SE | 196 | -6.99 | -3.44% | 4:00 pm GMT-5 | 2.86M | 3.36M | 47.53B |
| TAK | Takeda Pharmaceutical Company Limited | 14.75 | +0.19 | +1.30% | 4:00 pm GMT-5 | 2.15M | 2.54M | 45.95B |
| NVAX | Novavax, Inc. | 110.82 | -1.56 | -1.39% | 4:00 pm GMT-5 | 9.84M | 6.26M | 8.38B |
| VIR | Vir Biotechnology, Inc. | 38.7 | +1.05 | +2.79% | 4:00 pm GMT-5 | 1.47M | 1.67M | 5.07B |
| INO | Inovio Pharmaceuticals, Inc. | 4.75 | +0.14 | +3.04% | 4:00 pm GMT-5 | 4.94M | 4.40M | 999.33M |
- MarketWatch
Preliminary Israeli study shows fourth COVID booster doesn’t stop omicron infections
A fourth vaccine boost lifted antibodies, but omicron infections persisted, according to an unpublished study at an Israeli hospital
- FX Empire
A Busier Economic Calendar Puts the Pound in the Spotlight
While key stats put the Pound in focus, economic data from the Eurozone will also provide the EUR with direction. Up first, however, is the BoJ.
- Zacks
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Gilead Sciences (GILD) closed at $71.77, marking a -0.15% move from the previous day.
Sign in to view your followed lists
© 2022 Yahoo. All rights reserved.
